A fragile cancer immunotherapy agent “cGAMP” is delivered to tumor sites using tiny bubbles that protect it until it reaches its destination.
Broad-spectrum antivirals made from polymers
Polymer-based broad spectrum antivirals show activity against Zika, Ebola, HIV-1, the Herpes simplex virus, and now, SARS-CoV-2.
Universal donor lungs could shorten transplant waiting times
By changing the blood type in a set of donor lungs, researchers hope to one day create universal donor organs.
Decoding the language of cells with virtual modeling
To understand the progression of diseases, such as angiogenesis, researchers have turned to computers to model complex biological processes.
Computer simulations pave the way for improved mRNA vaccines
Molecular dynamics offer ways to improve lipid-based therapeutic delivery systems.
Omicron reduces vaccine efficacy, but boosters improve protection
Preliminary data indicates that booster shots improve antibody levels 25-fold compared to just two doses.
Real progress made this year in the fight against malaria
Antibody therapies and new vaccines have been added to the arsenal, giving hope to the millions who live where malaria is endemic.
Shining a light on more efficient nasal vaccines
Nanoparticulate formula together with light augmentation could realize the potential for intranasal vaccines to protect against respiratory viruses.
Study reveals what makes the Delta variant so infectious
A part of the SARS-CoV-2 spike protein could prove to be its Achilles’ heel.
Biomaterial-based COVID-19 vaccine shows adaptive immunity in mice
A biomaterials platform offers a stable center within the body for antibody development against SARS-CoV-2.